Uncategorised - European Medical Journal

ATS 2026: Ralinepag Trial Targets PAH Disease Progression

Ralinepag may offer once daily prostacyclin pathway targeting for PAH patients already receiving background therapy.

Systemic Lupus Erythematosus Linked to Repeat Pregnancy Risks

Systemic lupus erythematosus was associated with lower second delivery rates and recurrent pregnancy complications in a nationwide study.

Ixekizumab and Tirzepatide Deliver Dual Benefits in Psoriasis Trial

Combining ixekizumab with tirzepatide improved skin clearance and weight loss in adults with psoriasis and obesity in a Phase 3b trial.

Serial IUT for Rh Isoimmunization: A Case Report

Successful Late Intrauterine Transfusion for Severe Fetal Anemia Due to Rh Alloimmunization: A Case Report…

5 minutes with Muriel O'Byrne, Regeneron

To celebrate World Clinical Trials Day 2026, Muriel unpacks the top challenges and opportunities in the landscape today.

England Meets HIV Targets, But Inequalities Persist

New UKHSA report highlights lower testing uptake, PrEP access, and later diagnoses in Black African communities.

Clinician reviewing digital gout management information with a patient using a tablet.

Digital Gout Management Boosts Self-Management Outcomes

Smart gout management improved self-care, serum uric acid control, and renal markers in suburban patients.

Quantitative MRCP Enhances PSC Risk Prediction

Quantitative MRCP may improve risk prediction and clinical trial development in primary sclerosing cholangitis, an international study suggests.

Patient-centered consultation about pregnancy-associated breast cancer research priorities.

Pregnancy-Associated Breast Cancer Research Priorities Revealed

Pregnancy-associated breast cancer research priorities reveal urgent biological, clinical, and psychosocial gaps in patient care.

Neuroimaging Utilisation Rises Sharply Across Europe

Neuroimaging use rose across Europe between 2015 and 2022, with CT and MRI volumes increasing more than 40%, alongside marked regional disparities across 29 countries.